Cancer treatment could be revolutionised by the discovery of the origin cells which divide first.
Academic rigour, journalistic flair
Articles on Chemotherapy
Displaying 21 - 40 of 76 articles
When you think of viruses, you might think of the horrible illnesses they cause, like flu or Ebola. But now researchers are learning how to use the unique traits of viruses to treat disease.
Male and female tumors are different. Researchers are now hoping to exploit these sex-specific differences to treat brain cancer. This might improve survival for everyone.
People across the country show their support for breast cancer patients and survivors by wearing pink and raising money each October. A recent study of patients suggests ways to help all year.
We have no reliable way of knowing which patients’ cancer will return after surgery, so often chemotherapy is given to mop up any remaining cancer cells that may have gone undetected.
While more women than ever are surviving breast cancer, they often do so with bad side effects. Studies are showing that physical therapy early in the post-treatment phase can help.
Patients undergoing chemotherapy are at particular risk from food poisoning - but they aren’t being made aware how critical food safety is at home.
Headlines that 70% of women with breast cancer don’t need chemo need to be heeded with caution: it’s a very specific (but substantial) subtype that was studied.
A cancer is in remission when it can no longer be detected. But we only say it’s cured when it hasn’t come back for a certain time – and that differs for different cancers.
Circadian clocks regulate the timing of hundreds of processes in the cell, suggesting that matching medications with your biological clock could improve the outcome
Cancer doesn’t just grow uncontrollably. It has a smarter strategy than that.
A new silver-based compound that is less toxic with fewer side effects could hold the key to crippling cancer.
Cancer is the second leading cause of death globally. Mathematicians have joined the fight, developing models to both test cancer drug combinations and understand chemotherapy drug resistance.
Great strides have been made in cancer medicine over decades, but it’s important not to forget the growing role that kindness and empathy play in good care.
Improvements in survival rates for acute myeloid leukaemia have failed to keep pace with other leukaemias. That may be about to change.
We need to ensure cancer research addresses what matters most.
Already suffering debilitating side effects, chemotherapy patients could be made seriously ill by the food they eat.
AML can kill with surprising rapidity. Luckily new treatments are on the horizon.
Leukaemia used to be a death sentence. Now, the survival rate for the most common form in children is 85%. We can apply similar strategies to how we approach childhood brain cancer.
The majority of research suggests the benefits of mammography screening greatly outweigh the harms for women over age 40.
Top contributors
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Associate Professor (conjoint), Children's Cancer Institute
-
Research Fellow, ZERO2FIVE Food Industry Centre, Cardiff Metropolitan University
-
Professor of Sociology, Ball State University
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
International Medical Director of Monash IVF
-
Professor, Lifecourse and Intergenerational Health Research Group, University of Adelaide
-
Research Fellow, Centre for Medical Psychology & Evidence-based Decision-making, University of Sydney
-
Associate professor, University of Sydney
-
PhD Candidate, University of Sydney
-
Assistant Professor of Internal Medicine and Research Scientist, University of Michigan
-
Professor, Internal Medicine, University of Michigan
-
Senior Research Fellow in Evolutionary Ecology, Deakin University
-
Professor of Molecular Oncology, University of Bradford
-
Veronique Chachay is a Friend of The Conversation.
Research & Teaching Academic, The University of Queensland
